Best Stock to Buy Right Now: Constellation Brands vs. Anheuser-Busch InBev

In This Article:

Key Points

  • Shares of Constellation Brands have sold off this year amid slowing sales in recent quarters.

  • Anheuser-Busch is benefiting from its global diversification and brand momentum in key markets.

  • One of these beer stocks has a stronger growth outlook that could help it outperform going forward.

  • 10 stocks we like better than Anheuser-Busch InBev/NV ›

It's a matchup between two of the world's largest brewing companies with diverging fortunes in 2025. Shares of Constellation Brands (NYSE: STZ) are down 15% year to date as of this writing amid uncertainties regarding its import-heavy beer portfolio and the effect of tariffs on its U.S. market positioning.

In contrast, Anheuser-Busch InBev (NYSE: BUD) (also known as AB InBev) has emerged as an outperformer, with strong earnings momentum propelling the stock higher by 32% thus far this year to its highest level since 2021. Should investors ride the buzz with Anheuser-Busch for more upside, or does Constellation Brands present the opportunity to pick up a beaten-down industry leader at a discount?

Let's discuss which beer stock is the better pick for your portfolio today.

Beer bottles on a factory conveyor belt.
Image source: Getty Images.

The case for Constellation Brands

Constellation Brands is recognized for its premium positioning in the beer market, holding exclusive rights to sell the flagship Corona, Modelo Especial, and Pacifico brands in the United States. The company's success in marketing these high-end imports is shown by a record 15 years of beer volume sales gains. Modelo is currently the top-selling beer brand in the United States, having overtaken Anheuser-Busch's Bud Light since 2023.

However, changes in trade policy implemented by the Trump administration pose challenges for Constellation this year, as all its beer is produced in Mexico. The company is responding to 25% tariffs through several measures, including modest price hikes and cost-saving initiatives, while using U.S.-sourced inputs like barley to secure some U.S.-Mexico-Canada Agreement (USMCA) tariff exemptions. Nevertheless, the result is some near-term financial weakness.

Constellation Brands is cutting its medium-term outlook for sales and earnings through the next three years. For the year ahead, the company is now targeting adjusted earnings per share (EPS) of between $12.60 and $12.90, marking a 7.5% decline at the midpoint compared to fiscal 2025 (which ended Feb. 28). For fiscal 2027 and 2028, Constellation is projecting organic revenue growth between 2% and 4%, down from a prior forecast of 6% to 8%.

While these headline numbers are a setback, the bigger takeaway is that Constellation Brands continues to generate profitable growth and benefits from a loyal customer following.